Inventor · disambiguated record
Joseph Rubinfeld
Also filed as: RUBINFELD JOSEPH
29 granted patents·17 pending applications·1,074 citations·filing 1973–2005
98Inventor score
Top patents by PatentIndex Score
46 records- 0196US6998391B2Method for treating diseases associated with abnormal kinase activitySUPERGEN INC·Filed 2002·Granted Feb 14, 2006·115 cites·20 claims
- 0294US6319943B1Oral formulation for paclitaxelSUPERGEN INC·Filed 2000·Granted Nov 20, 2001·63 cites·23 claims
- 0393US6613753B2Restore cancer-suppressing functions to neoplastic cells through DNA hypomethylationSUPERGEN INC·Filed 2001·Granted Sep 2, 2003·43 cites·13 claims
- 0493US6538020B2Paclitaxel formulationSUPER GEN INC·Filed 2001·Granted Mar 25, 2003·41 cites·20 claims
- 0593US6509370B1Paclitaxel formulationSUPERGEN INC·Filed 2002·Granted Jan 21, 2003·36 cites·26 claims
- 0693US6136846AFormulation for paclitaxelSUPERGEN INC·Filed 1999·Granted Oct 24, 2000·113 cites·38 claims
- 0793US5730969AMethod and compositions for solubilization and stabilization of polypeptides, especially proteinsCHIRON CORP·Filed 1995·Granted Mar 24, 1998·133 cites·79 claims
- 0890US5602112APharmaceutical formulationSUPERGEN INC·Filed 1994·Granted Feb 11, 1997·70 cites·31 claims
- 0989US6420378B1Inhibition of abnormal cell proliferation with camptothecin and combinations including the sameSUPERGEN INC·Filed 2000·Granted Jul 16, 2002·21 cites·3 claims
- 1089US6284747B1Pharmaceutical formulationSUPERGEN INC·Filed 2000·Granted Sep 4, 2001·16 cites·16 claims
- 1188US6828346B2Methods for administration of paclitaxelSUPERGEN INC·Filed 2003·Granted Dec 7, 2004·26 cites·48 claims
- 1286US6710195B2Method for preparing and using polyoxyethylated castor oil in pharmaceutical compositionsSUPERGEN INC·Filed 2002·Granted Mar 23, 2004·21 cites·70 claims
- 1386US6583125B2Formulation of nitrogen mustardSUPERGEN INC·Filed 2001·Granted Jun 24, 2003·11 cites·14 claims
- 1486US5997856AMethod and compositions for solubilization and stabilization of polypeptides, especially proteinsCHIRON CORP·Filed 1989·Granted Dec 7, 1999·71 cites·24 claims
- 1584US6664233B1Combination therapy including 9-nitro-20(S)-camptothecin and bleomycinSUPERGEN INC·Filed 2000·Granted Dec 16, 2003·11 cites·4 claims
- 1684US6627614B1Sequential therapy comprising a 20(S)-camptothecin and an anthracyclineSUPER GEN INC·Filed 2002·Granted Sep 30, 2003·12 cites·53 claims
- 1782US6629995B1Camptothecin conjugatesSUPER GEN INC·Filed 2000·Granted Oct 7, 2003·16 cites·36 claims
- 1878US6017948AWater-miscible pharmaceutical compositionsSUPERGEN INC·Filed 1998·Granted Jan 25, 2000·45 cites·25 claims
- 1978US5824668AFormulation for administration of steroid compoundsSUPERGEN INC·Filed 1996·Granted Oct 20, 1998·56 cites·43 claims
- 2078US5804568APharmaceutical formulationSUPERGEN INC·Filed 1997·Granted Sep 8, 1998·32 cites·17 claims
- 2175US6191119B1Combination therapy including 9-nitro-20(S)-camptothecinSUPERGEN INC·Filed 1999·Granted Feb 20, 2001·29 cites·4 claims
- 2272US3952096AMixture of calcium carbonate and calcium-α-p-chlorophenoxyisobutyrate as an antihyperlipemic agentBRISTOL MYERS CO·Filed 1973·Granted Apr 20, 1976·10 cites·10 claims
- 2370US6218374B1Pharmaceutical formulationSUPERGEN INC·Filed 1999·Granted Apr 17, 2001·20 cites·10 claims
- 2470US6048845APharmaceutical formulationSUPERGEN INC·Filed 1998·Granted Apr 11, 2000·20 cites·28 claims
- 2568US3980588ADetergents containing olefin sulfonateCOLGATE PALMOLIVE CO·Filed 1974·Granted Sep 14, 1976·11 cites·4 claims
- 2668US2005130882A1Combination therapy including 9-nitro-20(S)-camptothecinFiled 2004·Application pending·0 cites
- 2767US2005118180A1Inhibition of abnormal cell proliferation with camptothecin and combinations including the sameFiled 2004·Application pending·0 cites
- 2864US2004224919A1Restoring cancer-suppressing functions to neoplastic cells through DNA hypomethylationFiled 2004·Application pending·0 cites
- 2964US2005209190A1Camptothecin complexesRUBINFELD JOSEPH·Filed 2004·Application pending·0 cites
- 3063US6977247B2Sequential therapy comprising a 20(S)-camptothecin and a pyrimidine base analogSUPERGEN INC·Filed 2002·Granted Dec 20, 2005·1 cites·10 claims
- 3163US4051315A6"-Deoxykanamycin B and 6"-deoxytobramycinBRISTOL MYERS CO·Filed 1975·Granted Sep 27, 1977·7 cites·4 claims
- 3263US2005043225A1Pharmaceutical formulationSUPERGEN INC·Filed 2004·Application pending·0 cites
- 3362US2004109846A1Restoring cancer-suppressing functions to neoplastic cells through DNA hypomethylationSUPERGEN INC·Filed 2003·Application pending·0 cites
- 3461US2004052864A1Restoring cancer-suppressing functions to neoplastic cells through DNA hypomethylationSUPERGEN INC·Filed 2003·Application pending·0 cites
- 3559US2002086818A1Combination therapy including 9-nitro-20(S)-camptothecin and 5-fluorouracilFiled 2002·Application pending·0 cites
- 3659US2004014695A1Pharmaceutical formulationSUPERGEN INC·Filed 2003·Application pending·0 cites
- 3759US2004097437A1Sequential therapy comprising a 20(S)-camptothecin and an anthracyclineSUPERGEN INC A DELAWARE CORP·Filed 2003·Application pending·0 cites
- 3859US2002111362A1Inhibition of abnormal cell proliferation with camptothecin and combinations including the sameFiled 2002·Application pending·0 cites
- 3958US2003148996A1Camptothecin complexesFiled 2002·Application pending·0 cites
- 4055US6436435B1Liposome formulation of 5 β steroidsSUPER GEN INC·Filed 1999·Granted Aug 20, 2002·13 cites·18 claims
- 4154US2005059682A1Compositions and methods for treatment of cancerSUPERGEN INC A DELAWARE CORP·Filed 2003·Application pending·0 cites
- 4252US2004167205A1Method for preparing and using polyoxyethylated castor oil in pharmaceutical compositionsSUPERGEN INC·Filed 2004·Application pending·0 cites
- 4351US2004116411A1Combination HIV therapy including camptothecinSUPERGEN INC A DELAWARE CORP·Filed 2003·Application pending·0 cites
- 4451US2006052334A1Sequential therapy comprising a 20(S)-camptothecian and a pyrimidine base analogRUBINFELD JOSEPH·Filed 2005·Application pending·0 cites
- 4550US4061603ADetergentsCOLGATE PALMOLIVE CO·Filed 1976·Granted Dec 6, 1977·11 cites·4 claims
- 4650US2006140947A1Method for treating diseases associated with abnormal kinase activityLYONS JOHN·Filed 2005·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →